News & Insights

OrbiMed Raises Over $4.3 Billion Across Private Investment Funds
OrbiMed Logo

Orbimed News

OrbiMed Raises Over $4.3 Billion Across Private Investment Funds

Read More
Filter by Type
All
Orbimed News
Portfolio News
PortCo1

Portfolio News

Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR

Read More
port-co

Portfolio News

Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine

Read More
Corvus Pharmaceuticals Logo

Portfolio News

Corvus Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial of...

Read More
scPharmaceuticals Logo

Portfolio News

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application...

Read More
ARS Pharma Logo

Portfolio News

ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal...

Read More
port-co

Portfolio News

Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I...

Read More
Perfuse Logo

Portfolio News

Perfuse Therapeutics Announces Positive Visual, Structural and Safety Data from a...

Read More
Adicet Bio Logo

Portfolio News

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of...

Read More
x4 Pharmaceuticals Logo

Portfolio News

X4 Pharmaceuticals and taiba rare Announce Exclusive Agreement for the...

Read More
ARS Pharma Logo

Portfolio News

ARS Pharmaceuticals Announces OptumRx, Cigna Healthcare and Navitus Health...

Read More
Springworks Logo

Portfolio News

SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for...

Read More
InspireMD Logo

Portfolio News

InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the...

Read More